{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T10:08:37Z","timestamp":1699524517383},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.vaccine.2014.11.001","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T04:05:02Z","timestamp":1415678702000},"page":"296-298","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of a current varicella vaccine as a live polyvalent vaccine vector"],"prefix":"10.1016","volume":"34","author":[{"given":"Kouki","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.11.001_bib0005","series-title":"Fields virology","first-page":"2731","article-title":"Varicella-zoster virus","author":"Arvin","year":"2001"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0010","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2014.11.001_bib0015","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1086\/522161","article-title":"Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2014.11.001_bib0020","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0025","series-title":"Human Herpesviruses: Biology,Therapy, and Immunoprophylaxis","first-page":"1262","article-title":"Varicella\u2013zoster vaccine","author":"Gershon","year":"2007"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1517\/14712598.4.2.199","article-title":"Effectiveness of live varicella vaccine","volume":"4","author":"Takahashi","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0035","series-title":"National Advisory Committee on Immunization (NACI): update on the use of herpes zoster vaccine","article-title":"An Advisory Committee Statement (ACS)","author":"National Advisory Committee on Immunization","year":"2014"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0040","series-title":"The Australian immunisation handbook","author":"National Health and Medical Research Council","year":"2013"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2807\/esm.10.01.00511-en","article-title":"Varicella zoster virus vaccination policies and surveillance strategies in Europe","volume":"10","author":"Pinot de Moira","year":"2005","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0050","doi-asserted-by":"crossref","first-page":"e1000971","DOI":"10.1371\/journal.ppat.1000971","article-title":"Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor","volume":"6","author":"Zhang","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0055","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.84.11.3896","article-title":"Varicella-zoster virus as a live vector for the expression of foreign genes","volume":"84","author":"Lowe","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2014.11.001_bib0060","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/0022-1317-72-6-1393","article-title":"Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen","volume":"72","author":"Shiraki","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jmv.1022","article-title":"Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen","volume":"64","author":"Shiraki","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0070","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.vaccine.2003.12.010","article-title":"Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge","volume":"22","author":"Heineman","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0075","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1016\/j.vaccine.2004.03.062","article-title":"Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli","volume":"22","author":"Nagaike","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0080","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0966-842X(02)02394-6","article-title":"Herpesvirus genetics has come of age","volume":"10","author":"Wagner","year":"2002","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0085","doi-asserted-by":"crossref","first-page":"8320","DOI":"10.1128\/JVI.73.10.8320-8329.1999","article-title":"Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants","volume":"73","author":"Borst","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0090","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1128\/JVI.77.9.5073-5083.2003","article-title":"Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis","volume":"77","author":"Chang","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0095","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1128\/JVI.78.13.7004-7015.2004","article-title":"Production of high-titer Epstein\u2013Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system","volume":"78","author":"Kanda","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0100","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1128\/JVI.76.13.6660-6668.2002","article-title":"Construction and manipulation of an infectious clone of the bovine herpesvirus 1 genome maintained as a bacterial artificial chromosome","volume":"76","author":"Mahony","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0105","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1073\/pnas.94.26.14759","article-title":"Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome","volume":"94","author":"Messerle","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0110","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1073\/pnas.080502497","article-title":"A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis","volume":"97","author":"Smith","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0115","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1128\/JVI.77.2.1382-1391.2003","article-title":"Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo","volume":"77","author":"Tanaka","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0120","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1128\/JVI.76.12.6185-6196.2002","article-title":"Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis","volume":"76","author":"Zhou","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0125","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1128\/JVI.77.15.8249-8255.2003","article-title":"Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo","volume":"77","author":"Cicin-Sain","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0130","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1099\/vir.0.80718-0","article-title":"Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning","volume":"86","author":"Gillet","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0135","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1128\/JVI.77.16.8712-8718.2003","article-title":"Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines","volume":"77","author":"Petherbridge","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0140","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1128\/JVI.79.5.2998-3008.2005","article-title":"Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception","volume":"79","author":"Redwood","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0145","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1128\/JVI.72.9.7137-7143.1998","article-title":"An enhanced packaging system for helper-dependent herpes simplex virus vectors","volume":"72","author":"Stavropoulos","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0150","doi-asserted-by":"crossref","first-page":"12697","DOI":"10.1073\/pnas.96.22.12697","article-title":"BAC-VAC, a novel generation of (DNA) vaccines: a bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1","volume":"96","author":"Suter","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0155","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1016\/j.vaccine.2007.04.064","article-title":"Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus","volume":"25","author":"Yoshii","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0160","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/JVI.67.3.1482-1492.1993","article-title":"Herpes simplex virus type 1 UL46 and UL47 deletion mutants lack VP11 and VP12 or VP13 and VP14, respectively, and exhibit altered viral thymidine kinase expression","volume":"67","author":"Zhang","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0165","doi-asserted-by":"crossref","first-page":"8741","DOI":"10.1016\/j.vaccine.2007.10.039","article-title":"Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin\u2013neuraminidase protein as a polyvalent live vaccine","volume":"25","author":"Somboonthum","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0170","series-title":"Fields virology","author":"Carbone","year":"2001"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0175","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2165\/00003495-200363190-00012","article-title":"Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella","volume":"63","author":"Wellington","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0180","first-page":"346","article-title":"Mumps virus, vaccines","volume":"76","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1442-200X.1996.tb03471.x","article-title":"Adverse events associated with MMR vaccines in Japan","volume":"38","author":"Kimura","year":"1996","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0190","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0140-6736(93)91069-X","article-title":"Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children","volume":"341","author":"Miller","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0195","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(89)92004-7","article-title":"Mumps vaccine complications: which strain?","volume":"2","author":"Nalin","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0200","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaci.2006.07.033","article-title":"Mumps resurgence in the United States","volume":"118","author":"Kancherla","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0205","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1099\/0022-1317-41-3-517","article-title":"Immunological properties of purified mumps virus glycoproteins","volume":"41","author":"Orvell","year":"1978","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0210","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.4049\/jimmunol.132.5.2622","article-title":"The reactions of monoclonal antibodies with structural proteins of mumps virus","volume":"132","author":"Orvell","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/IAI.35.1.179-186.1982","article-title":"Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein","volume":"35","author":"Server","year":"1982","journal-title":"Infect Immun"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2014.11.001_bib0220","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1099\/0022-1317-67-10-2259","article-title":"Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody","volume":"67","author":"Tsurudome","year":"1986","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0225","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/JVI.53.3.727-734.1985","article-title":"Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis","volume":"53","author":"Wolinsky","year":"1985","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0230","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1073\/pnas.90.15.7376","article-title":"Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro","volume":"90","author":"Cohen","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0235","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/1348-0421.12087","article-title":"Novel polyvalent live vaccine against varicella-zoster and mumps virus infections","volume":"57","author":"Matsuura","year":"2013","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2014.11.001_bib0240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.virol.2010.03.032","article-title":"Rapid and efficient introduction of a foreign gene into bacterial artificial chromosome-cloned varicella vaccine by Tn7-mediated site-specific transposition","volume":"402","author":"Somboonthum","year":"2010","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14015084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14015084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T01:10:42Z","timestamp":1689642642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14015084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0264410X14015084"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of a current varicella vaccine as a live polyvalent vaccine vector","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}